Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been significant developments in their design, the most notable of which has been the introduction of drug-eluting stents. This paper reviews the benefits, risks, and current status of Food and Drug Administration-approved drug-eluting stents.
Takashi Muramatsu, Yoshinobu Onuma, Yao‐Jun Zhang, Christos V. Bourantas, Alexander Kharlamov, Roberto Diletti, Vasim Farooq, Bill D. Gogas, Scot Garg, Héctor M. García‐García, Yukio Ozaki, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.